Innophos Holdings, Inc. Reports Second Quarter 2015 Results

Jul 27, 2015, 16:10 ET from Innophos Holdings, Inc.

CRANBURY, N.J., July 27, 2015 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ:  IPHS), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets, today announced its financial results for the second quarter 2015.

Second Quarter Results

  • Net sales for the second quarter 2015 of $217 million were down 1% compared to the second quarter 2014.  Consistent with the comparisons seen in the first quarter 2015, Specialty Phosphates sales declined 3% year-over-year due to 1% lower volumes and 2% lower selling prices.  
  • US/Canada Specialty Phosphates sales of $148 million were down 6% compared to the prior year quarter on 4% lower volumes and 2% lower selling prices.        
  • Mexico Specialty Phosphates sales of $44 million increased 7% compared to the year ago period on 10% higher volumes but 3% lower prices.
  • GTSP & Other sales of $25 million were up 17% versus the prior year quarter on higher volumes but lower prices.
  • Diluted EPS for the second quarter 2015 was $0.65, up 18% sequentially due to translation expense in the first quarter 2015 but down 30% when compared to $0.93 for the second quarter 2014.
  • During the second quarter, the Company repurchased through its enhanced buyback program 973,000 shares for $51.9 million. The Company also paid $9.9 million in dividends, returning a total of $61.8 million to shareholders. 

Randy Gress, CEO of Innophos, commented, "Similar to last quarter, we had pockets of notable performance this quarter, with year-over-year volume improvements for Cal-Rise®, INNOVALT® and PPA of 34%, 28% and 19%, respectively. Nevertheless, this strong performance was overshadowed by weak firefighting demand, reduced sales to specialty horticulture markets due to unfavorable pricing conditions, continued headwinds on processed foods market demand and pricing pressures due to the strong US dollar. Despite these challenges, we generated significant cash flow during the quarter which we used to increase returns to our shareholders.  We repurchased more shares during the second quarter 2015 than the entire $50 million buyback program previously implemented in 2011, returning more than four times our net income to shareholders through buybacks and dividends. We have now completed nearly 70% of our announced $125 million share buyback program for 2015."

Mr. Gress concluded, "Given the 2015 margin compression that we are experiencing, we are currently evaluating several initiatives to improve the overall operating efficiency of the organization, targeting to at least cover the 100 basis points cost component of the margin compression. These initiatives may require various one-time costs such as capital spending, involuntary and/or voluntary separation costs. The various initiatives being reviewed include production unit consolidations and various staff reduction initiatives.  We intend to conclude the evaluation of these initiatives and seek Board approval by the end of the third quarter 2015."

Segment Results – second quarter 2015 versus 2014

Specialty Phosphates

Specialty Phosphates sales decreased 3% year-over-year due to 1% lower volumes and 2% lower selling prices.  The strong US dollar continued to facilitate increased pricing pressures from European competitors and certain markets were also affected by lower pricing from Chinese competitors.    

Operating income of $21 million was $11 million below the prior year period due to lower selling prices and higher costs.  Operating income margin was 11%, down 520 basis points compared to the same period in 2014 when Mexico recorded an exceptional margin quarter.

US/Canada

Sales were down 6% compared to the prior year quarter on 4% lower volumes and 2% lower selling prices, which improved from the 3% selling price decline reported for year-over-year first quarter 2015 results.  Soft demand in firefighting markets and reduced sales to specialty horticulture markets, due to low Chinese pricing, accounted for the entire volume decline. 

Operating income of $13 million was $8 million below the prior year period on lower selling prices and higher costs. Operating income margin was 9%, down 450 basis points compared to the same period in 2014.

Mexico 

Mexico Specialty Phosphates sales increased 7% compared to the year ago period on 10% higher volumes due to a 41% improvement in PPA. Selling prices declined 3% compared to a very strong second quarter 2014.

Second quarter 2015 operating income of $7 million was down $3 million versus the comparable 2014 quarter.  Operating income margin remained strong at 17% but was down 840 basis points compared with a very strong prior year period when price increases were achieved ahead of cost increases.

GTSP & Other

GTSP & Other sales (primarily Granulated Triple Superphosphate fertilizer co-product) were up $4 million versus second quarter 2014 on 28% higher volumes but 11% lower selling prices.     

The second quarter 2015 break-even operating income was in line with expectations and flat with the prior year quarter.  Operating income margin of 2% was similar to the 1% recorded in the second quarter 2014.    

Recent Trends and Outlook

Financial performance in the second quarter mirrored the first quarter 2015, with not much change regarding the overall business drivers and challenges.  Specialty Phosphates volumes were down 1% for the second quarter 2015 compared to the prior year period.  Soft firefighting and processed foods market demand, competitive pricing pressures and the strong US dollar effects seen since the fourth quarter 2014 continued through the second quarter 2015.  Export sales were down 5% year-over-year for the second quarter due to order patterns for Europe, Middle East and Africa and lingering effects on sales to Asia from the dockworkers slowdown at US West Coast ports, which returned to normal operations during the quarter. The Specialty Phosphates volume outlook continues to be flat for full year 2015 compared to 2014, with the second half 2015 year-over-year comparable expected to recover first half 2015 shortfalls due to low second half 2014 PPA volumes caused by supply issues during that period.

Specialty Phosphates operating income margins were 11% for the second quarter 2015, and the first half 2015 margin of 12% was at the low end of the expected full year range. Recently implemented selling price increases are expected to improve margins in the second half of the year from the second quarter 2015 levels, maintaining management's full year expectation for margins in the 12-13% range.   

Given the 2015 margin compression that the Company is experiencing, management is currently evaluating several initiatives to improve the overall operating efficiency of the organization, targeting to at least cover the 100 basis points cost component of the margin compression. These initiatives may require various one-time costs such as capital spending, involuntary and/or voluntary separation costs. The various initiatives being reviewed include production unit consolidations and various staff reduction initiatives.  The Company intends to conclude the evaluation of these initiatives and seek Board approval by the end of the third quarter 2015.

Reported fertilizer market prices showed a slightly declining trend during the second quarter of 2015 and are currently 5-10% below prior year levels.  Demand improved sequentially due to seasonality but still remained weaker than normal.  Market phosphate rock prices were stable sequentially in the second quarter 2015 and are expected to remain stable for the third quarter.  Sulfur market prices decreased approximately 10% sequentially in the second quarter 2015 and are expected to remain stable for the third quarter.    

GTSP & Other recorded break-even operating income for the second quarter 2015, in line with expectations and the prior year quarter. The company expects an operating result close to break-even for the third quarter as well.

Net debt increased sequentially by just $16 million in the second quarter 2015 while $62 million was returned to shareholders. The strong cash flow was aided by a $29 million decrease in working capital which more than reversed the $21 million working capital increase in the first quarter 2015.

Capital Expenditures

Capital expenditures were $8 million in the second quarter 2015 with approximately 70% of the spending on maintenance and approximately 30% on growth projects.  Management still expects 2015 capital expenditures to be in the $30-35 million range. 

About Innophos Holdings, Inc.

Innophos is a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets.  Innophos combines more than a century of experience in specialty phosphate manufacturing with a growing capability in a broad range of other specialty ingredients to supply a product range produced to stringent regulatory manufacturing standards and the quality demanded by customers worldwide.  Innophos is continually developing new and innovative specialty ingredients addressing specific customer applications and supports these high-value products with industry-leading technical service.  Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Ogden, UT; North Salt Lake, UT; Salt Lake City, UT; Paterson, NJ; Green Pond, SC; Port Maitland, ON (Canada); Taicang (China); Coatzacoalcos, Veracruz and San Jose de Iturbide (Mission Hills), Guanajuato (Mexico). For more information please visit www.innophos.com. 'IPHS-G'


Financial Tables Follow



Innophos Holdings, Inc.                             

FTI Consulting, Inc.



Investor Relations: (609) 366-1299          

Bryan Armstrong

investor.relations@innophos.com             

(312) 553-6707



Conference Call Details   

The conference call is scheduled for Tuesday, July 28, 2015 at 10:00 am ET and can be accessed by dialing 1-800-446-2782 (U.S.) or 1-847-413-3235 (international) and entering passcode 40304894.  Please dial in approximately 15 minutes ahead of the start time to ensure timely entry to the call.  A replay will be available between 1:00 pm ET on July 28 and 1:00 pm ET on August 11, 2015.  The replay is accessible by dialing 1-888-843-7419 (U.S.) or 1-630-652-3042 (international) and entering passcode 4030 4894#.

Safe Harbor for Forward-Looking and Cautionary Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.  As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon suppliers; and other risks.  For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.

Summary Profit & Loss Statement – Second Quarter

INNOPHOS HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statement of Operations (Unaudited)

(Dollars In thousands, except per share amounts or share amounts)






 

Three Months Ended June 30,


2015


2014





Net sales

$217,294


$219,542

Cost of goods sold

176,299


166,969

Gross profit

40,995


52,573

Operating expenses:




     Selling, general and administrative

18,667


19,683

     Research & development expenses

1,063


1,081

     Total operating expenses

19,730


20,764

Operating income

21,265


31,809

Interest expense, net

1,403


1,128

Foreign exchange loss (gain)

117


(1,042)

Income before income taxes

19,745


31,723

Provision for income taxes

6,142


11,095

Net income

$13,603


$20,628





Diluted Earnings Per Participating Share

$0.65


$0.93

Diluted weighted average participating shares outstanding:

20,722,940


22,251,416

Dividends paid per share of common stock

$0.48


$0.40

Dividends declared per share of common stock

$0.48


$0.40

 

Segment Reporting – Second Quarter

The Company reports its operations in three segments: Specialty Phosphates US & Canada, Specialty Phosphates Mexico and GTSP & Other.  The primary performance indicators for the chief operating decision maker are sales and operating income, with sales presented on a ship-from basis.  Sales on a ship-from basis are on the same revenue recognition principle as a ship-to basis and are recognized when delivery has occurred and title and risk of loss passes to the customer.  The following table sets forth the historical results of these indicators by segment:          

 


 

Three Months Ended June 30,


Net Sales


2015


2014


% Change

Segment Net Sales






Specialty Phosphates US & Canada

$148,376


$157,267


(5.7)%

Specialty Phosphates Mexico

43,886


40,885


7.3%

Total Specialty Phosphates

192,262


198,152


(3.0)%

GTSP & Other

25,032


21,390


17.0%

Total

$217,294


$219,542


(1.0)%







Segment Operating Income






Specialty Phosphates US & Canada

$13,470


$21,334



Specialty Phosphates Mexico

7,362


10,320



Total Specialty Phosphates

20,832


31,654



GTSP & Other

433


155



Total

$21,265


$31,809









Segment Operating Income %  of net sales






Specialty Phosphates US & Canada

9.1%


13.6%



Specialty Phosphates Mexico

16.8%


25.2%



Total Specialty Phosphates

10.8%


16.0%



GTSP & Other

1.7%


0.7%



Total

9.8%


14.5%









Depreciation and amortization expense






Specialty Phosphates US & Canada

$6,786


$6,291



Specialty Phosphates Mexico

3,196


2,277



Total Specialty Phosphates

9,982


8,568



GTSP & Other

780


357



Total

$10,762


$8,925









 

Price / Volume – Second Quarter

The Company calculates pure selling price dollar variances as the selling price for the current year to date period minus the selling price for the prior year to date period, and then multiplies the resulting selling price difference by the prior year to date period volume.  The current quarter selling price dollar variance is derived from the current quarter year to date selling price dollar variance less the previous quarter year to date selling price dollar variance.  The selling price dollar variance is then divided by the prior period sales dollars to calculate the percentage change.  Volume variance is calculated as the total sales variance minus the selling price variance and refers to the revenue effect of changes in tons sold at the relative prices applicable to the variation in tons, otherwise known as volume/mix.

The following tables illustrate for the three months ended June 30, 2015 the percentage changes in net sales by reportable segments and by Specialty Phosphates product lines compared with the same period of the prior year, including the effect of selling price and volume/mix changes upon revenue:

 

Reportable Segments

  Price  


Volume/Mix


  Total  


Specialty Phosphates US & Canada

(1.7)%


(4.0)%


(5.7)%


Specialty Phosphates Mexico

(3.3)%


10.6%


7.3%


Total Specialty Phosphates

(2.0)%


(1.0)%


(3.0)%


GTSP & Other

(11.0)%


28.0%


17.0%


Total

(2.9)%


1.9%


(1.0)%























Specialty Phosphates Product Lines

  Price  


Volume/Mix


  Total  


Specialty Ingredients

(2.1)%


(5.2)%


(7.3)%


Food & Technical Grade PPA

(3.6)%


18.7%


15.1%


STPP & Detergent Grade PPA

1.5%


(6.0)%


(4.5)%


Summary Cash Flow Statement 

 

INNOPHOS HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

(Dollars in thousands)






 

Six months ending June 30,


2015


2014

Cash flows provided from operating activities




     Net income

$25,546


$34,813

     Adjustments to reconcile net income to net cash provided




     from operating activities:




          Depreciation and amortization

20,633


17,399

          Amortization of deferred financing charges

285


263

          Deferred income tax provision 

135


(71)

          Share-based compensation

1,585


1,975

     Changes in assets and liabilities:




         Increase in accounts receivable

(10,876)


(19,307)

         Decrease in inventories

9,573


17,200

         Decrease in other current assets

13,969


12,154

         Decrease in accounts payable

(4,144)


(920)

         (Decrease) increase in other current liabilities

(1,589)


2,543

         Changes in other long-term assets and liabilities

135


1,978

                Net cash provided from operating activities

55,252


68,027

Cash flows used for investing activities:




      Capital expenditures

(14,146)


(14,722)

               Net cash used for investing activities

(14,146)


(14,722)

Cash flows used for financing activities:




     Proceeds from exercise of stock options

190


159

     Long-term debt borrowings

110,000


-

     Long-term debt repayments

(2,002)


(24,001)

     Excess tax benefits from exercise of stock options

764


154

     Common stock repurchases and restricted stock forfeitures

(86,248)


(6,381)

     Dividends paid

(20,061)


(17,546)

              Net cash provided from (used for) financing activities

2,643


(47,615)

Effect of foreign exchange rate changes on cash and cash equivalents

38


23

Net change in cash

43,787


5,713

Cash and cash equivalents at beginning of period

36,207


32,755

Cash and cash equivalents at end of period

$79,994


$38,468

 

Summary Balance Sheets 

INNOPHOS HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(Dollars In thousands)






June 30,
2015


December 31,
2014

ASSETS




Current assets:




     Cash and cash equivalents

$79,994


$36,207

     Accounts receivable, net

101,427


90,551

     Inventories

175,044


184,621

     Other current assets

46,348


60,135

               Total current assets

402,813


371,514

Property, plant and equipment, net

197,037


198,988

Goodwill

84,373


84,373

Intangibles and other assets, net

68,387


73,536

               Total assets

$752,610


$728,411

LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:




     Current portion of long-term debt

$4,003


$4,003

     Accounts payable, trade and other

48,922


53,137

     Other current liabilities

34,112


34,806

               Total current liabilities

87,037


91,946

Long-term debt

240,000


132,002

Other long-term liabilities

40,858


41,456

               Total stockholders' equity

384,715


463,007

               Total liabilities and stockholders' equity

$752,610


$728,411

 

Additional Information

Net debt is a supplemental financial measure that is not required by, or presented in accordance with, USGAAP.  The Company believes net debt is helpful in analyzing leverage and as a performance measure for purposes of presentation in this release. The Company defines net debt as total long-term debt (including any current portion) less cash and cash equivalents.

 

SOURCE Innophos Holdings, Inc.



RELATED LINKS

http://www.innophos.com